Structural requirements for galanin interaction with receptors from pancreatic beta cells and from brain tissue of the rat.

Peptides
I Lagny-PourmirM Laburthe

Abstract

The binding activity of several galanin fragments and analogs was measured on specific receptors present in rat brain and the rat pancreatic beta cell line Rin m 5F. In both tissues it was observed that: 1) galanin(3-29), galanin(10-29) and [Ile2]-galanin were ineffective for inhibiting [125I] galanin binding and 2) active peptides had the following rank order of potency: galanin(1-29) greater than [Ac-Trp2]-galanin(2-29) greater than galanin(2-29) greater than galanin(1-15) greater than [Phe2]-galanin greater than [Tyr2]-galanin. It was concluded that the N-terminal portion of galanin is very important for interaction with central or peripheral receptors. The aromatic amino acid in position 2 (Trp in native galanin) plays a crucial role.

References

May 27, 1986·European Journal of Pharmacology·T MelanderE Brodin
Apr 14, 1987·Biochemical and Biophysical Research Communications·A L ServinM Laburthe
Oct 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·G FisoneT Hökfelt
Feb 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·L M KaplanW W Chin
Mar 14, 1988·FEBS Letters·B AhrénP O Berggren
Sep 1, 1988·Diabetes·B E Dunning, G J Taborsky
Apr 12, 1989·European Journal of Pharmacology·B AmiranoffM Laburthe
Jul 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·B E EvansR M Freidinger

❮ Previous
Next ❯

Citations

Jan 1, 1995·Journal of Molecular Neuroscience : MN·M C BurgevinE Habert-Ortoli
Aug 24, 1993·European Journal of Pharmacology·W J RossowskiD H Coy
Aug 1, 1992·Trends in Pharmacological Sciences·T BartfaiU Langel
Dec 11, 1992·Regulatory Peptides·H A JohardD R Nässel
Jul 2, 1993·Regulatory Peptides·N YanaiharaC Yanaihara
Sep 22, 1995·Regulatory Peptides·J N Crawley
Dec 28, 1995·Brain Research. Molecular Brain Research·E M ParkerM E Goldstein
Jul 1, 1991·Peptides·R SillardH Jörnvall
Mar 1, 1992·Peptides·Y ChenB Amiranoff
Sep 15, 1994·European Journal of Pharmacology·A M LorinetB Amiranoff
Jun 11, 2005·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·A UmerR P Korolkiewicz
Jan 1, 1994·Baillière's Clinical Endocrinology and Metabolism·M LaburtheT Voisin
Dec 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·T BartfaiS Nilsson
May 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·Y ChenB Amiranoff
Oct 11, 1994·Proceedings of the National Academy of Sciences of the United States of America·E Habert-OrtoliJ F Mayaux
Mar 22, 1996·Annals of the New York Academy of Sciences·P B Hedlund, K Fuxe
Feb 3, 1999·Annals of the New York Academy of Sciences·N YanaiharaC Yanaihara
Dec 10, 1999·Proceedings of the National Academy of Sciences of the United States of America·Z Q XuT Hökfelt
Oct 1, 1991·The Journal of Comparative Neurology·C T LundquistD R Nässel
May 15, 1991·Biochemical and Biophysical Research Communications·B GirosJ C Schwartz
Apr 3, 1999·Neuropeptides·E Karelson, U Langel
Oct 15, 1990·Biochemical and Biophysical Research Communications·B GallwitzW Creutzfeldt
Jun 29, 2001·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·R P KorolkiewiczJ Petrusewicz
Sep 11, 1998·The Journal of Comparative Neurology·M LandryT Hökfelt
Sep 1, 1991·International Journal of Peptide and Protein Research·T LandT Bartfai
Jun 1, 1992·International Journal of Peptide and Protein Research·U LangelT Bartfai

❮ Previous
Next ❯

Related Concepts

Related Feeds